Skip to main content

Peer Review reports

From: Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study

Original Submission
4 Oct 2012 Submitted Original manuscript
24 Nov 2012 Reviewed Reviewer Report - William Jacot
26 Jan 2013 Reviewed Reviewer Report - Maggie Cheang
3 Mar 2013 Author responded Author comments - Jianghao Chen
Resubmission - Version 2
3 Mar 2013 Submitted Manuscript version 2
11 Mar 2013 Reviewed Reviewer Report - William Jacot
23 Mar 2013 Author responded Author comments - Jianghao Chen
Resubmission - Version 3
23 Mar 2013 Submitted Manuscript version 3
Publishing
14 May 2013 Editorially accepted
21 May 2013 Article published 10.1186/1471-2407-13-248

You can find further information about peer review here.

Back to article page